Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,025 | 3 | 48.5% |
| Food and Beverage | $7,286 | 346 | 32.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,695 | 2 | 11.8% |
| Travel and Lodging | $1,598 | 12 | 7.0% |
| Education | $147.67 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $11,817 | 25 | $0 (2024) |
| Genentech USA, Inc. | $3,539 | 10 | $0 (2024) |
| ABBVIE INC. | $1,835 | 128 | $0 (2024) |
| EMD Serono, Inc. | $1,397 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $659.63 | 31 | $0 (2024) |
| PFIZER INC. | $544.34 | 62 | $0 (2024) |
| SK Life Science, Inc. | $353.36 | 6 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $328.12 | 11 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $323.45 | 3 | $0 (2022) |
| TG Therapeutics, Inc. | $305.30 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,336 | 147 | Eisai Inc. ($11,662) |
| 2023 | $6,432 | 127 | Genentech USA, Inc. ($3,324) |
| 2022 | $1,067 | 69 | ABBVIE INC. ($322.00) |
| 2021 | $917.01 | 24 | Biohaven Pharmaceuticals, Inc. ($328.12) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/24/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: PAIN | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: AMANTADINE | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $37.89 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Neurology | ||||||
| 11/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $105.27 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $120.57 | General |
| Category: Immunology | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: PAIN | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 222 | 319 | $86,417 | $30,192 |
| 2022 | 4 | 214 | 251 | $73,394 | $27,381 |
| 2021 | 2 | 39 | 39 | $12,677 | $5,077 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 206 | $50,058 | $17,095 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $30,528 | $11,084 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $5,831 | $2,013 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $31,764 | $11,326 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 114 | $27,301 | $10,513 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $8,841 | $3,388 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $5,488 | $2,154 | 39.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $8,904 | $3,567 | 40.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,773 | $1,511 | 40.0% |
About Dr. Fred Odago, MD
Dr. Fred Odago, MD is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2017. The National Provider Identifier (NPI) number assigned to this provider is 1356872238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fred Odago, MD has received a total of $22,752 in payments from pharmaceutical and medical device companies, with $14,336 received in 2024. These payments were reported across 367 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($11,025).
As a Medicare-enrolled provider, Odago has provided services to 475 Medicare beneficiaries, totaling 609 services with total Medicare billing of $62,651. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Lexington, KY
- Active Since 03/23/2017
- Last Updated 06/14/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1356872238
Products in Payments
- Leqembi (Drug) $11,767
- Ocrevus (Biological) $3,539
- MAVENCLAD (Drug) $1,165
- NURTEC ODT (Drug) $918.85
- BOTOX (Biological) $764.43
- KESIMPTA (Drug) $636.74
- QULIPTA (Drug) $624.22
- UBRELVY (Drug) $495.19
- BRIUMVI (Drug) $305.30
- XCOPRI (Drug) $297.32
- ZEPOSIA (Drug) $218.05
- INGREZZA (Drug) $126.00
- PONVORY (Drug) $104.51
- Soliris (Drug) $88.25
- ULTOMIRIS (Biological) $86.13
- Gocovri (Drug) $85.64
- COMIRNATY (Biological) $75.21
- TYSABRI (Biological) $67.00
- Ponvory (Drug) $62.19
- EMGALITY (Drug) $58.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615
John Slevin, Md, MD
Neurology — Payments: $16,946